Kilitch Drugs (India) is currently trading at Rs. 111.80, up by 3.50 points or 3.23% from its previous closing of Rs. 108.30 on the BSE.
The scrip opened at Rs. 107.60 and has touched a high and low of Rs. 112.00 and Rs. 107.60 respectively. So far 85 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 242.40 on 23-Jan-2019 and a 52 week low of Rs. 93.40 on 06-Aug-2019.
Last one week high and low of the scrip stood at Rs. 114.70 and Rs. 105.30 respectively. The current market cap of the company is Rs. 172.55 crore.
The promoters holding in the company stood at 68.97%, while Institutions and Non-Institutions held 0.26% and 30.77% respectively.
Kilitch Drugs (India) is nearing to complete the establishment of a world class manufacturing unit with State of the art facility at Addis Ababa, Ethiopia to cater not only to Ethiopia but all surrounding countries in an incremental way and it is expected to commence operations in the current financial year.
Kilitch Drugs (India) is an India-based company engaged in pharmaceutical business. The Company’s services range from manufacturing to marketing a host of formulations in all dosage forms, such as solid, liquid and parenteral forms.